about
The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease miceDisrupting self-assembly and toxicity of amyloidogenic protein oligomers by "molecular tweezers" - from the test tube to animal modelsAPP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).Short-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease miceProtein restriction cycles reduce IGF-1 and phosphorylated Tau, and improve behavioral performance in an Alzheimer's disease mouse model.Long-term hydrocephalus alters the cytoarchitecture of the adult subventricular zoneDeficits in memory-guided limb movements impair obstacle avoidance locomotion in Alzheimer's disease mouse modelA novel Alzheimer's disease drug candidate targeting inflammation and fatty acid metabolism.A novel, rapidly acquired and persistent spatial memory task that induces immediate early gene expression.Long- and short-term CDK5 knockdown prevents spatial memory dysfunction and tau pathology of triple transgenic Alzheimer's miceA behavioral paradigm to evaluate hippocampal performance in aged rodents for pharmacological and genetic target validationA shortened Barnes maze protocol reveals memory deficits at 4-months of age in the triple-transgenic mouse model of Alzheimer's disease.Dissecting the age-related decline on spatial learning and memory tasks in rodent models: N-methyl-D-aspartate receptors and voltage-dependent Ca2+ channels in senescent synaptic plasticityA mouse model replicating hippocampal sparing cranial irradiation in humans: A tool for identifying new strategies to limit neurocognitive decline.Characterizing cognitive aging of spatial and contextual memory in animal modelsNeuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.Neurologic and motor dysfunctions in APP transgenic mice.Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's diseaseLearning impairments identified early in life are predictive of future impairments associated with agingMolecular biomarkers of lung carcinoma.Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer's disease transgenic miceAngiotensin II-inhibition: effect on Alzheimer's pathology in the aged triple transgenic mouse.Permanent deficits in brain functions caused by long-term ketamine treatment in mice.Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease.Spatial learning impairments in PLB1Triple knock-in Alzheimer mice are task-specific and age-dependent.Rigor and Reproducibility in Rodent Behavioral Research.Reduced blood-brain barrier expression of fatty acid-binding protein 5 is associated with increased vulnerability of APP/PS1 mice to cognitive deficits from low omega-3 fatty acid diets.Learning ability is a key outcome determinant of GSK-3 inhibition on visuospatial memory in rats.Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer's disease.Erythropoietin protects newborn rat against sevoflurane-induced neurotoxicity.Cyclohexane produces behavioral deficits associated with astrogliosis and microglial reactivity in the adult hippocampus mouse brain.Effect of Edible Bird's Nest Extract on Lipopolysaccharide-Induced Impairment of Learning and Memory in Wistar Rats
P2860
Q21195685-0B999DFA-1AE6-49CE-843F-6BA06CC80A86Q26995918-2FD565F4-2D9B-4287-83AA-8E7F90EC88FDQ30455082-CD36A07A-4A38-4CFC-9D63-19F56AE32360Q30541295-DF4DA720-C0B6-4FBB-A561-E3649F09682CQ30575876-AEF6838D-BD3D-4BA6-9C63-1208C4375052Q30591480-D55E4EC9-C410-4B0A-AB7E-3AFFB83E661BQ30602249-696F92DD-1A23-49C2-9E47-018B5FB7AFC7Q33909566-A3C78386-D723-4D84-9EE4-DA786B0C89A6Q34025621-4DA8F17B-F322-4DC5-BB4D-236011F67399Q34159111-4E963751-0457-4AE2-9211-8D91F1C97F49Q34717172-56A59E35-2581-48C3-B52C-A3568F59BE99Q35043942-5650C4EA-A289-4FE7-925B-77C98729B1C1Q35840136-305F6037-CE66-4E59-AD23-00C211C298E2Q36099797-5D313C83-4B3F-4E79-974D-46DFBBE86E70Q36227699-91D7786B-F9D0-4877-BCAA-C67B89999C0AQ36259188-7D6BD314-88E3-43DF-925D-17BA8153BF22Q36347389-3C24598D-5E09-4FEE-A4CF-235FE0808CBAQ36997908-2916DAEE-07E7-40D2-958B-A7000DC01920Q37038510-D7FDEF5D-F1C1-41B4-828D-42E347F2FC9AQ37971659-968498C3-1630-41CC-94FE-EA602FC05CC0Q38280315-196D901E-1E7F-4830-BCE4-49724B8CA180Q42069095-6624CB06-3E32-4436-A983-099EE9447418Q44348194-40A9DC49-8931-43EE-974F-8ADBB861CCA6Q45297446-5FA07B29-719B-4C9B-B3C0-1AF8E7ED1017Q45924774-1B542EBD-DB7A-4361-9BAD-D175993FE95BQ47200848-C63A8613-FA82-4463-8420-BD94DF6874B1Q47439026-1F161E6A-4068-4631-BDF5-F3C41850AC1EQ47736903-70202860-4065-4050-BD5E-43FCA369D631Q47784892-7D4EE9D1-B198-4246-8BD0-A5FC06637F52Q47885183-11A87E5D-BA61-4B82-A5D8-D28B6B1E7442Q48443933-59D2BEB9-168C-46E0-966A-C61EDE283210Q58780521-0D2FD1B6-0F35-4D2D-A383-ECD5B37E9B1C
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Validation of a 2-day water maze protocol in mice.
@ast
Validation of a 2-day water maze protocol in mice.
@en
Validation of a 2-day water maze protocol in mice.
@nl
type
label
Validation of a 2-day water maze protocol in mice.
@ast
Validation of a 2-day water maze protocol in mice.
@en
Validation of a 2-day water maze protocol in mice.
@nl
prefLabel
Validation of a 2-day water maze protocol in mice.
@ast
Validation of a 2-day water maze protocol in mice.
@en
Validation of a 2-day water maze protocol in mice.
@nl
P2093
P2860
P1476
Validation of a 2-day water maze protocol in mice.
@en
P2093
Brian P Schoenfeld
Catherine H Choi
Donald S Faber
Frank LaFerla
Guadalupe Mendoza
Maria Gulinello
Michael Gertner
Salvatore Oddo
Sean M J McBride
P2860
P304
P356
10.1016/J.BBR.2008.09.002
P407
P577
2008-09-11T00:00:00Z